Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Effective Targeting of Multiple B-Cell Maturation Antigen-Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells.

Friedman KM, Garrett TE, Evans JW, Horton HM, Latimer HJ, Seidel SL, Horvath CJ, Morgan RA.

Hum Gene Ther. 2018 May;29(5):585-601. doi: 10.1089/hum.2018.001.

2.

Akt1 and -2 inhibition diminishes terminal differentiation and enhances central memory CD8+ T-cell proliferation and survival.

Abu Eid R, Friedman KM, Mkrtichyan M, Walens A, King W, Janik J, Khleif SN.

Oncoimmunology. 2015 Feb 3;4(5):e1005448. eCollection 2015 May.

3.

Selective inhibition of regulatory T cells by targeting the PI3K-Akt pathway.

Abu-Eid R, Samara RN, Ozbun L, Abdalla MY, Berzofsky JA, Friedman KM, Mkrtichyan M, Khleif SN.

Cancer Immunol Res. 2014 Nov;2(11):1080-9. doi: 10.1158/2326-6066.CIR-14-0095. Epub 2014 Jul 30.

4.

Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes.

Friedman KM, Prieto PA, Devillier LE, Gross CA, Yang JC, Wunderlich JR, Rosenberg SA, Dudley ME.

J Immunother. 2012 Jun;35(5):400-8. doi: 10.1097/CJI.0b013e31825898c5.

PMID:
22576345
5.

Augmented lymphocyte expansion from solid tumors with engineered cells for costimulatory enhancement.

Friedman KM, Devillier LE, Feldman SA, Rosenberg SA, Dudley ME.

J Immunother. 2011 Nov-Dec;34(9):651-61. doi: 10.1097/CJI.0b013e31823284c3.

6.

The promising future of proteomics in cancer diagnosis and treatment.

Friedman KM, Fox BA.

Eur J Gastroenterol Hepatol. 2005 Jul;17(7):701-3.

PMID:
15947545
7.

Internet prescribing limitations and alternatives.

Friedman KM.

Ann Health Law. 2001;10:139-78.

PMID:
11496587
8.

Editorial: Cigarette smoking and public policy.

Friedman KM.

Am J Public Health. 1975 Sep;65(9):979-80. No abstract available.

Supplemental Content

Loading ...
Support Center